Kovar, Lukas
Selzer, Dominik
Britz, Hannah
Benowitz, Neal
St. Helen, Gideon
Kohl, Yvonne
Bals, Robert
Lehr, Thorsten http://orcid.org/0000-0002-8372-1465
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (031L0153, 03XP0196)
National Institute on Drug Abuse (DA039264, DA012393)
Article History
First Online: 12 March 2020
Compliance with Ethical Standards
:
: This project has received funding from the German Federal Ministry of Education and Research (BMBF), 031L0153, “Alternativmethoden zum Tierversuch” and 03XP0196, “NanoCare4.0 - Anwendungssichere Materialinnovationen”. Data used for model development were collected in part with the support of grants DA039264 and DA012393 from the National Institute on Drug Abuse, USA.
: Neal Benowitz has been a consultant to Pfizer and Achieve Life Sciences, companies that market or are developing smoking cessation medications. He has also been a paid witness in litigation against tobacco companies. Lukas Kovar, Dominik Selzer, Hannah Britz, Gideon St.Helen, Yvonne Kohl, Robert Bals, and Thorsten Lehr have no conflicts of interest that are directly relevant to the content of this article.